Pharma Blogs and Articles
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Pharma Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

NewsDealsSocialBlogsVideosPodcasts
HomeIndustryPharmaBlogsCryo-EM Reveals New Aspects of CRISPR-Cas Biology
Cryo-EM Reveals New Aspects of CRISPR-Cas Biology
PharmaBioTech

Cryo-EM Reveals New Aspects of CRISPR-Cas Biology

•March 3, 2026
BioTechniques (independent journal site)
BioTechniques (independent journal site)•Mar 3, 2026
0

Key Takeaways

  • •Cryo‑EM resolved 11 CRISPR‑Cas supercomplex structures.
  • •Cas9 participates in spacer acquisition, not just DNA cleavage.
  • •Csn2 facilitates assembly of Cas9‑Cas1‑Cas2 supercomplex.
  • •Findings may improve precision of gene‑editing tools.
  • •Insight could inspire CRISPR‑based data storage methods.

Summary

Researchers at Vilnius University used cryogenic electron microscopy to map eleven CRISPR‑Cas protein complexes, including three variants of a newly described Cas9‑Cas1‑Cas2‑Csn2 supercomplex. The study shows that Cas9, traditionally viewed only as a DNA‑cutting enzyme, also directs the selection and integration of viral DNA fragments (spacers) during the adaptation phase of bacterial immunity. Structural analysis revealed Csn2’s role in assembling the supercomplex and clarified how spacers are incorporated into the CRISPR locus. These findings broaden the functional portrait of Cas9 and suggest new avenues for biotechnological innovation.

Pulse Analysis

Cryogenic electron microscopy has become a cornerstone for visualizing macromolecular machines at near‑atomic resolution, and the latest Vilnius University work leverages this power to dissect the early stages of CRISPR immunity. By capturing eleven distinct configurations of the Cas protein ensemble, researchers illuminated how the adaptation phase—where bacteria capture short viral DNA snippets—operates at a structural level. The data reveal a previously unappreciated supercomplex that unites Cas9 with the canonical Cas1‑Cas2 integrase and the auxiliary ring protein Csn2, providing a mechanistic blueprint for spacer selection and insertion.

The discovery that Cas9 actively participates in spacer acquisition reshapes the canonical view of this enzyme as merely a nuclease. In the supercomplex, Cas9 helps recognize suitable viral fragments, while Csn2 acts as a scaffold, aligning the DNA and recruiting Cas1‑Cas2 for integration into the CRISPR array. This coordinated choreography explains how bacteria build a durable genetic memory of past infections, ensuring rapid response upon re‑exposure. The structural snapshots also clarify how conformational changes within the complex trigger downstream processing, offering a template for engineering synthetic systems that mimic natural immunity.

Beyond basic microbiology, these insights have tangible implications for biotechnology. A more nuanced grasp of Cas9’s multifunctionality could inform the design of next‑generation genome‑editing tools with enhanced specificity and reduced off‑target effects. Moreover, the detailed mechanism of spacer integration opens possibilities for CRISPR‑based data storage, where engineered bacteria could archive digital information within their genomes. As the field moves toward increasingly sophisticated applications, the Vilnius study underscores the value of fundamental structural research as a catalyst for innovation.

Cryo-EM reveals new aspects of CRISPR-Cas biology

Read Original Article

Comments

Want to join the conversation?